Special drug use survey of Tremfya for Psoriasis
Not Applicable
- Conditions
- Psoriasis, Psoriatic arthritis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis
- Registration Number
- JPRN-UMIN000032969
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of the use of ustekinumab (active ingredient of this product)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method